DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lotrel (Amlodipine Besylate / Benazepril Hydrochloride) - Published Studies


Lotrel Related Published Studies

Well-designed clinical trials related to Lotrel (Amlodipine / Benazepril)

Comparative efficacy and safety of amlodipine/benazepril combination therapy and amlodipine monotherapy in severe hypertension. [2010.06]

An eight-week, multicenter, randomized, double-blind study to evaluate the efficacy and tolerability of fixed-dose amlodipine/benazepril combination in comparison with amlodipine as first-line therapy in chinese patients with mild to moderate hypertension. [2008.06]

The effects of high-dose amlodipine/benazepril combination therapies on blood pressure reduction in patients not adequately controlled with amlodipine monotherapy. [2007.03]

Efficacy of combination therapy with amlodipine besylate/benazepril hydrochloride for lowering systolic blood pressure in stage 2 hypertension. [2006.05]

Efficacy of combination therapy for systolic blood pressure in patients with severe systolic hypertension: the Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) study. [2005.11]

Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy. [2004.07]

Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients. [2003.08]

Effect of benazepril addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. [2003.03]

Comparison of benazepril-amlodipine and captopril-thiazide combinations in the management of mild-to-moderate hypertension. [2002.06]

Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone. [2001.07]

Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension. [2000.12.01]

Combined therapy with benazepril and amlodipine in the treatment of hypertension inadequately controlled by an ACE inhibitor alone. [1997.10]

Fixed combination of benazepril and low-dose amlodipine in the treatment of mild to moderate essential hypertension: evaluation by 24-hour noninvasive ambulatory blood pressure monitoring. [1997.08]

Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo. [1996.11]

Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: a randomized, double-blind, placebo-controlled, parallel-group study. The Benazepril/Amlodipine Study Group. [1995.11]

Pharmacokinetic interaction study between benazepril and amlodipine in healthy subjects. [1994]

Well-designed clinical trials possibly related to Lotrel (Amlodipine / Benazepril)

Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study. [2008.06]

Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy. [2005.04]

Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes. [2005.03]

Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension. [2005.02]

Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. [2004.06]

Effect of antihypertensive monotherapy and combination therapy on arterial distensibility and left ventricular mass. [2004.01]

Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approaches. [2003.05]

Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study. [2002.03]

Blood pressure reduction in the morning yields beneficial effects on progression of chronic renal insufficiency with regression of left ventricular hypertrophy. [2002.01]

[CEA comprehensive evaluation for Western and traditional Chinese hypotensive drugs] [2001.09]

Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists. [2001.09]

Comparison of the effects of an ACE inhibitor and alphabeta blocker on the progression of renal failure with left ventricular hypertrophy: preliminary report. [2001.03]

Other research related to Lotrel (Amlodipine / Benazepril)

Comparative efficacy and safety of amlodipine/benazepril combination therapy and amlodipine monotherapy in severe hypertension. [2010]

Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy. [2008]

The effects of high-dose amlodipine/benazepril combination therapies on blood pressure reduction in patients not adequately controlled with amlodipine monotherapy. [2007.03.01]

Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy. [2003.11]

Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting. [2003.06]

Combination therapy of amlodipine/benazepril versus monotherapy of amlodipine in a practice-based setting. [2002.06]

Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension. [2001.08]

Amlodipine/benazepril: fixed dose combination therapy for hypertension. [2001.01]

Other possibly related research studies

Creating a combination antihypertensive regimen: what does the research show? [2003.07]

The Avoiding Cardiovascular events through COMbination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a comparison of first-line combination therapies. [2005.02]

[Vasopressin analogue injection as ultimate measure for counteracting severe catecholamine-refractory poisoning by several vasodilators taken with suicidal intent] [2003.10.17]

The first hypertension trial comparing the effects of two fixed-dose combination therapy regimens on cardiovascular events: Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH). [2003.07]

Rationale for combination therapy as initial treatment for hypertension. [2003.07]

The effects of antihypertensive agents on the survival rate of polycystic kidney disease in Han:SPRD rats. [2002.11]

Anastrozole: in early breast cancer. [2002]

Intensive blood pressure reduction is beneficial in patients with impaired cardiac function coexisting with chronic renal insufficiency. [2002.01]

Prescribing patterns and cost of antihypertensive drugs in an internal medicine clinic. [2001.05]

Low Dose Combination Therapy vs. High Dose Monotherapy in the Management of Hypertension. [1999.11]

Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up. [2000.11]

Fixed-dose combination vs monotherapy in hypertension: a meta-analysis evaluation. [1999.07]

Relationship between endothelial function and fibrinolysis in early hypertension. [1998.01]

Combined effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on renal injury. [1997.10]

Cost containment for treating hypertension in African Americans: impact of a combined ACE inhibitor-calcium channel blocker. [1997.07]

Trough/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists. [1996.07]

Biochemical components and myocardial performance after reversal of left ventricular hypertrophy in spontaneously hypertensive rats. [1993.09]

Magnetic resonance imaging left ventricular mass reduction with fixed-dose Angiotensin-converting enzyme inhibitor-based regimens in patients with high-risk hypertension. [2009.10]

Renoprotective effects of benazepril: current perspective. [2011.06]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017